These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2841654)

  • 1. [Enalapril--an oral angiotensin-converting enzyme inhibitor: its pharmacological properties and clinical use].
    Wiecek A; Grzeszczak W
    Pol Tyg Lek; 1988 Feb; 43(9):279-83. PubMed ID: 2841654
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors.
    Ciabatti R; Tarzia G; Battaglia F; Barone D; Baldoli E
    Farmaco Sci; 1988 Dec; 43(12):989-1003. PubMed ID: 2854788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
    Gubert S; Braso MA; Sacristán A; Ortiz JA
    Farmaco; 1990 Jan; 45(1):59-79. PubMed ID: 2186741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
    Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
    J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enalapril: a new angiotensin-converting enzyme inhibitor.
    McRaith J; Fitz A
    Iowa Med; 1986 Oct; 76(10):482, 484, 486-8. PubMed ID: 3023256
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of enalapril. Summing up the evidence.
    Dollery CT
    J Hypertens Suppl; 1983 Oct; 1(1):155-7. PubMed ID: 6100605
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronological structure of arterial pressure in hypertensive patients on enalapril].
    Gapon LI; Gubin DG; Semukhin EN; Gubin GD
    Klin Med (Mosk); 2001; 79(3):56-9. PubMed ID: 11490421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiotensin-converting enzyme inhibitors in angina pectoris].
    Rietbrock N; Thürmann P
    Dtsch Med Wochenschr; 1988 Sep; 113(37):1455-6. PubMed ID: 2843343
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats.
    Crespo MJ; Dunbar DC
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1311-8. PubMed ID: 14984003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of 24-hour ambulatory blood pressure monitoring in cases of intermittent acute porphyria with hypertension: special reference to safety and efficacy of angiotensin-converting enzyme inhibitor (enalapril) therapy.
    Bandyopadhyay M; Gupta BK; Panwar RB; Kabra PK; Kaushik AN; Chadda VS
    Indian Heart J; 2002; 54(6):734. PubMed ID: 12674196
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker.
    Saleh FH; Jurjus AR
    J Pathol; 2001 Mar; 193(3):415-20. PubMed ID: 11241424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [24-hour ambulatory monitoring of blood pressure in patients with essential hypertension: the effectiveness of enalapril therapy].
    Siegelová J; Fiser B; Dusek J
    Vnitr Lek; 1996 Feb; 42(2):98-101. PubMed ID: 8686198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic effects of a novel dihydrobenzofuran analogue and enalapril on blood pressure and plasma and tissue angiotensin converting enzyme activity in the sodium deficient normotensive rat.
    Longman SD; Howlett DR
    Arzneimittelforschung; 1988 May; 38(5):678-82. PubMed ID: 2843192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the slow pressor effect of angiotensin II contributes to the antihypertensive effect of angiotensin-converting enzyme inhibitors in renovascular hypertension.
    Melaragno MG; Fink GD
    J Pharmacol Exp Ther; 1996 Jul; 278(1):297-303. PubMed ID: 8764363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lisinopril: a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Noble TA; Murray KM
    Clin Pharm; 1988 Sep; 7(9):659-69. PubMed ID: 2853660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of action and clinical use of converting enzyme inhibitors].
    Lazowski J; Rewerski W
    Pol Tyg Lek; 1986 Dec; 41(48):1507-11. PubMed ID: 3035518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.